Predict your next investment

Trellis Bioscience company logo
Corporation
HEALTHCARE | Biotechnology
trellisbio.com

See what CB Insights has to offer

Competitors

15

Business Relationships

4

Trellis Bioscience Competitors & Alternatives

15 Competitors

Trellis Bioscience has 15 competitors. Trellis Bioscience's competitors are Oligomerix, Array Biopharma, Threshold Pharmaceuticals, Cellerant Therapeutics, Tau Therapeutics and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

9/15/2020

Grant - III

$13.28M

New York

7/30/2019

Acq - P2P

$32.81M

Colorado

8/2/2017

Merger

$50.8M

California

4/13/2016

Debt - III

$64.54M

California

8/28/2014

Merger

$13.68M

Virginia

8/22/2013

Regado Biosciences

IPO

$173.63M

New Jersey

12/2/2010

Transave

Merger

$75.5M

New Jersey

6/7/2010

Ascenta Therapeutics

Acquired

$87.3M

Pennsylvania

6/15/2009

Chroma Therapeutics

Series D

$103.3M

United Kingdom

4/25/2005

Exelixis

IPO

$23.86M

California

Latest Funding

9/15/2020

7/30/2019

8/2/2017

4/13/2016

8/28/2014

8/22/2013

12/2/2010

6/7/2010

6/15/2009

4/25/2005

Companies

Regado Biosciences

Transave

Ascenta Therapeutics

Chroma Therapeutics

Exelixis

Investment Stage

Grant - III

Acq - P2P

Merger

Debt - III

Merger

IPO

Merger

Acquired

Series D

IPO

Total Funding

$13.28M

$32.81M

$50.8M

$64.54M

$13.68M

$173.63M

$75.5M

$87.3M

$103.3M

$23.86M

Mosaic

Location

New York

Colorado

California

California

Virginia

New Jersey

New Jersey

Pennsylvania

United Kingdom

California

Trellis Bioscience Partners & Customers

4 Partners and customers

Trellis Bioscience has 4 strategic partners and customers. Trellis Bioscience recently partnered with CMC Biologics on August 8, 2017.

Date

Type

Business Partner

Country

News Snippet

Sources

8/8/2017

Partner

CMC Biologics

Denmark

CMC Biologics, Trellis sign long-term agreement to advance mAbs

CMC Biologics and Trellis Bioscience LLC have entered into a manufacturing agreement for the process development and production of two of Trellis Bioscience LLC ' monoclonal antibodies .

1

8/2/2017

Vendor

AGC Biologics

United States

Subscribe to see more

Subscribe to see more

10

3/17/2014

Partner

Amorfix Life Sciences

Canada

Subscribe to see more

Subscribe to see more

10

4/1/2007

Licensee

ContraFect

United States

Subscribe to see more

Subscribe to see more

10

Date

8/8/2017

8/2/2017

3/17/2014

4/1/2007

Type

Partner

Vendor

Partner

Licensee

Business Partner

CMC Biologics

AGC Biologics

Amorfix Life Sciences

ContraFect

Country

Denmark

United States

Canada

United States

News Snippet

CMC Biologics, Trellis sign long-term agreement to advance mAbs

CMC Biologics and Trellis Bioscience LLC have entered into a manufacturing agreement for the process development and production of two of Trellis Bioscience LLC ' monoclonal antibodies .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.